[1]
|
Xu Y, Wang L, He J, et al.Prevalence and control of diabetes in Chinese adults[J].JAMA, 2013, 310(9):948-959. |
[2]
|
Kota SK, Kota SK, Meher LK, et al.Surgical revascularization techniques for diabetic foot[J].J Cardiovasc Dis Res, 2013, 4(2):79-83. |
[3]
|
Tuttolomondo A, Maida C, Pinto A.Diabetic foot syndrome:Immune-inflammatory features as possible cardiovascular markers in diabetes[J].World J Orthop, 2015, 6(1):62-76. |
[4]
|
Assaad-Khalil SH, Zaki A, Rehim AA, et al.Prevalence of diabetic foot disorders and related risk factors among Egyptian subjects with diabetes[J].Prim Care Diab, 2015, 9(4):297-303. |
[5]
|
Haji Zaine N, Burns J, Vicaretti M, et al.Characteristics of diabetic foot ulcers in Western Sydney, Australia[J].J Foot Ankle Res, 2014, 7(1):39-45. |
[6]
|
章容.内皮祖细胞在糖尿病血管病变中的作用及干预治疗[J].国际病理科学与临床杂志, 2009, 29(4):353-356. |
[7]
|
Zuberi SI, Syed EU, Bhatti JA.Association of depression with treatment outcomes in Type 2 Diabetes Mellitus:a cross-sectional study from Karachi, Pakistan[J].BMC Psychiatry, 2011, 11(1):27-32. |
[8]
|
鹏园国.糖尿病周围神经病变的病因机制研究探讨[J].中国医药指南, 2014, 12(17):397-398. |
[9]
|
岳宗相,曾洪长,谢春光,等.糖尿病血管并发症病因学研究进展[J].现代临床医学, 2012, 38(4):247-250. |
[10]
|
王萍,王晶,章秋.糖尿病足及溃疡发生的临床特点分析[J].中华临床医师杂志, 2011, 5(9):2628-2632. |
[11]
|
黄根牙,顾新元.C反应蛋白致动脉粥样硬化的作用[J].国际心血管病杂志, 2008, 35(6):363-366. |
[12]
|
Mahendra JV, Satish Kumar D, Anuradha TS, et al.Plasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relation with Ischemic Heart Disease(IHD) and Retinopathy[J].J Clin Diagn Res, 2015, 9(1):BC18-BC21. |
[13]
|
Weigeh C, Rose B, Poschen U, et al.Immune mediators in patients with acute diabetic foot syndrome[J].Diabetes Care, 2009, 32(8):1491-1496. |
[14]
|
Rattan R, Nayak D.High levels of plasma malondialdehyde, protein carbonyl, and fibrinogen have prognostic potential to predict poor outcomesin patients with diabetic foot wounds:a preliminary communication[J].Int J Low Extrem Wounds, 2008, 7(4):198-203. |
[15]
|
左红,王速进,杨华,等.糖尿病足合并感染患者血清高敏C反应蛋白和纤维蛋白原浓度变化及其相关性研究[J].陕西医学杂志, 2012, 41(2):203-204. |
[16]
|
Finney H, Newman DJ, Gmber W.Initial evaluatin of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems(BNA, BN Ⅱ)[J].Clin Chem, 1997, 43(6 Pt 1):1016-1022. |
[17]
|
Fehrman-Ekholm I, Seeberger A, Björk J, et al.Serum cystatin C:a useful marker of kidney function in very old people[J].Scand J Clin Lab Invest, 2009, 69(5):606-611. |
[18]
|
Weinert LS, Prates AB, do Amaral FB, et al.Gender does not influence cystatin C concentrations in healthy volunteers[J].Clin Chem Lab Med, 2010, 48(3):405-408. |
[19]
|
Tsai HT, Wang PH, Tee YT, et al.Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease[J].Fertil Steril, 2009, 91(2):549-555. |
[20]
|
Magdalena Luczak, Dorota Formanowicz, Lukasz Marcza, et al.Deeper insight into chronic kidney disease-related atherosclerosis:comparative proteomic studies of blood plasma using 2DE and mass spectrometry[J].J Transl Med, 2015, 13(1):20-38. |
[21]
|
吴棋阳,李曲文,蔡俊峰.脂蛋白(a)及D-二聚体检测在下肢骨折并发深静脉血栓早期诊断中的价值[J].实验诊断与临床, 2014, 36(6):90-91. |